Maladie de Fabry (déficit en alpha-galactosidase A) : Physiopathologie, signes cliniques et aspects génétiques
J. Soc. Biol., 196 2 (2002) 161-173
Published online: 2017-04-04
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Neurootologische Manifestationen bei Morbus Fabry – eine retrospektive Analyse
Katharina Storck, Anna Stenzl, Claudia Regenbogen, Benedikt Hofauer and Andreas KnopfHNO 72 (1) 16 (2024)
https://doi.org/10.1007/s00106-023-01360-4
Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients
Marco Marenco, Marco Segatto, Marta Sacchetti, et al.Orphanet Journal of Rare Diseases 17 (1) (2022)
https://doi.org/10.1186/s13023-022-02441-3
First phenotypic description of a female patient with c.610 T > C variant of GLA: a renal-predominant presentation of Fabry disease
Sophie Greillier, Laurent Daniel, Catherine Caillaud, et al.BMC Medical Genetics 21 (1) (2020)
https://doi.org/10.1186/s12881-020-01071-5
Multidisciplinary approach to Fabry disease: from the eye of a neurologist
Rahşan İnan, Meral Meşe and Zerrin BicikActa Neurologica Belgica 120 (6) 1333 (2020)
https://doi.org/10.1007/s13760-019-01138-y
Quantitative Analysis of Conjunctival and Retinal Vessels in Fabry Disease
Andrea Sodi, Chiara Lenzetti, Daniela Bacherini, et al.Journal of Ophthalmology 2019 1 (2019)
https://doi.org/10.1155/2019/4696429
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease
Giuseppe Cammarata, Simone Scalia, Paolo Colomba, et al.Oncotarget 9 (44) 27333 (2018)
https://doi.org/10.18632/oncotarget.25542
Fabry’s disease: an example of cardiorenal syndrome type 5
Aashish Sharma, Marco Sartori, Jose J. Zaragoza, et al.Heart Failure Reviews 20 (6) 689 (2015)
https://doi.org/10.1007/s10741-015-9500-0
Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy
Eefje B. Suntjens, Bouwien E. Smid, Marieke Biegstraaten, Wouter A. Dreschler, Carla E. M. Hollak and Gabor E. LinthorstJournal of Inherited Metabolic Disease 38 (2) 351 (2015)
https://doi.org/10.1007/s10545-014-9783-7
Mitochondria and Their Role in Cardiovascular Disease
José Marín-GarcíaMitochondria and Their Role in Cardiovascular Disease 245 (2013)
https://doi.org/10.1007/978-1-4614-4599-9_12
Electron Microscopy in End Stage Renal Disease: A Case of Fabry's Disease
Adriana M. Doldan-Silvero, Gretl Nunnemacher, Michael Germain and Giovanna M. CrisiUltrastructural Pathology 34 (5) 307 (2010)
https://doi.org/10.3109/01913121003802389
Fabry Disease and Chemosis
Jayson D Edwards, Kraig S Bower, Dain B Brooks and Angela WalterCornea 28 (2) 224 (2009)
https://doi.org/10.1097/ICO.0b013e318183a3f8
Psychosis in a patient with Fabry's disease and treatment with aripiprazole
Yu-Chih Shen, Lee Haw-Ming, Chaucer C.H. Lin and Chia-Hsiang ChenProgress in Neuro-Psychopharmacology and Biological Psychiatry 31 (3) 779 (2007)
https://doi.org/10.1016/j.pnpbp.2006.11.017
Post-Genomic Cardiology
JOSÉ MARÍN-GARCÍAPost-Genomic Cardiology 165 (2007)
https://doi.org/10.1016/B978-012373698-7/50007-3
Manifestations neurologiques de la maladie de Fabry
P. Clavelou, G. Besson, C. Elziere, et al.Revue Neurologique 162 (5) 569 (2006)
https://doi.org/10.1016/S0035-3787(06)75051-2
Histologic and electron microscopy findings in myocardium of treated Fabry disease
Christopher L. Owens, Stuart D. Russell and Marc K. HalushkaHuman Pathology 37 (6) 764 (2006)
https://doi.org/10.1016/j.humpath.2006.01.021
Atteinte vasculaire et remodelage ventriculaire gauche dans la maladie de Fabry
Pierre Boutouyrie, Elie Mousseaux, Benjamin Cocheteux, Stéphane Laurent and Dominique P. Germainmédecine/sciences 21 30 (2005)
https://doi.org/10.1051/medsci/20052111s30
Maladie de Fabry - Place du dermatologue et progrès thérapeutiques
E. Mahé, S. Hadj-Rabia, D. Chauveau and Y. De ProstAnnales de Dermatologie et de Vénéréologie 132 (2) 171 (2005)
https://doi.org/10.1016/S0151-9638(05)79234-6
Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients
M Senechal and DP GermainClinical Genetics 63 (1) 46 (2003)
https://doi.org/10.1034/j.1399-0004.2003.630107.x
Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients
Christophe Orssaud, Jean Louis Dufier and Dominique Paul GermainOphthalmic Genetics 24 (3) 129 (2003)
https://doi.org/10.1076/opge.24.3.129.15609
Arterial remodelling in Fabry disease
P Boutouyrie, S Laurent, B Laloux, O Lidove, JP Grunfeld and DP GermainActa Paediatrica 91 (s439) 62 (2002)
https://doi.org/10.1111/j.1651-2227.2002.tb03113.x
Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients
Dominique P Germain, Paul Avan, Augustin Chassaing and Pierre BonfilsBMC Medical Genetics 3 (1) (2002)
https://doi.org/10.1186/1471-2350-3-10
Endothelial markers and homocysteine in patients with classic Fabry disease
K Demuth and DP GermainActa Paediatrica 91 (s439) 57 (2002)
https://doi.org/10.1111/j.1651-2227.2002.tb03112.x